Sharma East India Hosp and Medical Research Ltd
₹ 113
9.04%
05 Jun
- close price
About
Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services[1]
Key Points
- Market Cap ₹ 37.0 Cr.
- Current Price ₹ 113
- High / Low ₹ 234 / 73.9
- Stock P/E 29.8
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 9.47 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of -5.61% over last 3 years.
- Debtor days have increased from 82.3 to 116 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.36 | 17.21 | 17.14 | 16.00 | 14.73 | 16.17 | 8.13 | 17.04 | 20.73 | 18.52 | 29.87 | 35.93 | |
| 15.11 | 16.33 | 15.51 | 14.54 | 14.09 | 14.24 | 8.79 | 14.79 | 17.43 | 20.40 | 26.21 | 32.30 | |
| Operating Profit | 1.25 | 0.88 | 1.63 | 1.46 | 0.64 | 1.93 | -0.66 | 2.25 | 3.30 | -1.88 | 3.66 | 3.63 |
| OPM % | 7.64% | 5.11% | 9.51% | 9.12% | 4.34% | 11.94% | -8.12% | 13.20% | 15.92% | -10.15% | 12.25% | 10.10% |
| 0.55 | 0.22 | 0.26 | 0.07 | 1.11 | 0.03 | 2.83 | 0.06 | 0.06 | 5.31 | 0.31 | 0.16 | |
| Interest | 0.76 | 0.48 | 1.08 | 0.73 | 0.88 | 1.15 | 0.69 | 0.70 | 1.18 | 0.95 | 0.72 | 0.51 |
| Depreciation | 0.61 | 0.59 | 0.70 | 0.62 | 0.52 | 0.43 | 0.65 | 0.78 | 1.39 | 1.48 | 1.84 | 1.72 |
| Profit before tax | 0.43 | 0.03 | 0.11 | 0.18 | 0.35 | 0.38 | 0.83 | 0.83 | 0.79 | 1.00 | 1.41 | 1.56 |
| Tax % | -30.23% | 33.33% | 27.27% | 27.78% | 22.86% | 18.42% | 24.10% | 18.07% | -5.06% | 34.00% | 12.06% | 20.51% |
| 0.57 | 0.03 | 0.08 | 0.13 | 0.27 | 0.31 | 0.64 | 0.68 | 0.83 | 0.66 | 1.24 | 1.24 | |
| EPS in Rs | ||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 35% |
| 3 Years: | 20% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 45% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 45% |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -1% |
| 3 Years: | -6% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 |
| Reserves | 2.03 | 2.05 | 3.32 | 3.46 | 3.73 | 4.12 | 4.76 | 5.44 | 6.41 | 7.07 | 8.32 | 9.56 |
| 5.97 | 6.47 | 7.51 | 5.38 | 10.89 | 7.42 | 5.98 | 4.35 | 8.30 | 5.04 | 2.26 | 7.29 | |
| 2.36 | 2.68 | 2.65 | 3.28 | 3.35 | 4.16 | 3.98 | 5.11 | 4.84 | 8.89 | 12.94 | 11.91 | |
| Total Liabilities | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.68 | 32.92 |
| 6.58 | 6.01 | 6.40 | 6.07 | 4.73 | 4.41 | 5.51 | 6.85 | 9.10 | 7.70 | 9.37 | 8.45 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.01 | 0.35 | 1.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.31 | 0.31 | 1.79 | 1.79 | 1.80 | 1.89 | 1.89 | 1.89 | 2.05 | 2.05 | 2.05 | 2.05 |
| 7.63 | 9.04 | 9.45 | 8.41 | 15.25 | 11.82 | 11.48 | 10.32 | 12.56 | 15.41 | 16.26 | 22.42 | |
| Total Assets | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.68 | 32.92 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.20 | -0.14 | 0.82 | 3.12 | -1.43 | 1.21 | 1.40 | 2.03 | 1.28 | -1.13 | 6.69 | -3.86 | |
| -0.02 | -0.01 | -0.77 | -0.25 | 1.65 | -1.50 | 2.79 | -2.11 | -3.63 | 5.17 | -3.26 | -0.65 | |
| -0.81 | 0.19 | -0.08 | -2.80 | 4.74 | -4.74 | -2.16 | -1.78 | 2.77 | -4.20 | -3.50 | 4.52 | |
| Net Cash Flow | -1.03 | 0.05 | -0.03 | 0.06 | 4.96 | -5.03 | 2.03 | -1.86 | 0.41 | -0.17 | -0.06 | 0.01 |
| Free Cash Flow | -0.70 | -0.68 | 0.05 | 2.86 | 0.22 | -0.29 | 4.19 | -0.09 | -2.36 | 4.01 | 3.35 | -4.66 |
| CFO/OP | -6% | -14% | 53% | 218% | -212% | 66% | -232% | 96% | 39% | 45% | 189% | -95% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46.63 | 57.69 | 49.40 | 74.14 | 85.49 | 107.22 | 120.32 | 72.61 | 75.54 | 50.85 | 79.92 | 116.21 |
| Inventory Days | 16.83 | 73.23 | 98.98 | 217.45 | 49.38 | 41.71 | 225.64 | 211.14 | 81.39 | |||
| Days Payable | 138.49 | 120.54 | 143.83 | 481.49 | 390.76 | 304.84 | 1,659.09 | 418.28 | 102.76 | |||
| Cash Conversion Cycle | -75.04 | 10.37 | 49.40 | 29.29 | 85.49 | 107.22 | -143.72 | -268.77 | -187.59 | -1,382.61 | -127.23 | 94.85 |
| Working Capital Days | 100.40 | 27.15 | 20.87 | 18.71 | -75.08 | 46.50 | 48.04 | 35.99 | -2.64 | -115.89 | 2.69 | 15.64 |
| ROCE % | 8.93% | 4.11% | 8.60% | 6.50% | 1.57% | 8.87% | -8.30% | 10.61% | 12.00% | -18.61% | 12.77% | 11.58% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Median Remuneration of Employees INR |
|
||||||
| Number of Permanent Employees Number |
|||||||
| Trade Receivables Turnover Ratio Times |
|||||||
| Share of Consultants (Professional Fees) INR Lakhs |
|||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jun - The Copy of newspaper advertisement of publication of audited financial results for the quarter and year ended March 31 2026.
-
Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026
31 May - FY26 audited results approved May 30, 2026; auditors issued unmodified opinion.
- Board Meeting Outcome for Outcome Of Board Meeting Held On May 30, 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations. 2015. 30 May
-
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026.
15 May - Board meeting on May 30, 2026 to approve audited FY26 financial results; trading window closed since April 1.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Company confirms it is not a Large Corporate as of 31 March 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
SEIHMR is provides medical & healthcare services. It runs a NABH accredited multi specialty hospital viz. Jaipur Hospital at Lal Kothi, Tonk Road, Jaipur.